These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 20816828)
1. Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β(1-40) administration in mice: evidence for dissociation between cognitive deficits and neuronal damage. Piermartiri TC; Figueiredo CP; Rial D; Duarte FS; Bezerra SC; Mancini G; de Bem AF; Prediger RD; Tasca CI Exp Neurol; 2010 Dec; 226(2):274-84. PubMed ID: 20816828 [TBL] [Abstract][Full Text] [Related]
2. Atorvastatin Prevents Cognitive Deficits Induced by Intracerebroventricular Amyloid-β1-40 Administration in Mice: Involvement of Glutamatergic and Antioxidant Systems. Martins WC; dos Santos VV; dos Santos AA; Vandresen-Filho S; Dal-Cim TA; de Oliveira KA; Mendes-de-Aguiar CB; Farina M; Prediger RD; Viola GG; Tasca CI Neurotox Res; 2015 Jul; 28(1):32-42. PubMed ID: 25827781 [TBL] [Abstract][Full Text] [Related]
3. Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice. Santos DB; Peres KC; Ribeiro RP; Colle D; dos Santos AA; Moreira EL; Souza DO; Figueiredo CP; Farina M Exp Neurol; 2012 Feb; 233(2):767-75. PubMed ID: 22173317 [TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-β (Aβ(1-40)) administration in mice. dos Santos VV; Santos DB; Lach G; Rodrigues AL; Farina M; De Lima TC; Prediger RD Behav Brain Res; 2013 May; 244():107-15. PubMed ID: 23396168 [TBL] [Abstract][Full Text] [Related]
5. Differential susceptibility following beta-amyloid peptide-(1-40) administration in C57BL/6 and Swiss albino mice: Evidence for a dissociation between cognitive deficits and the glutathione system response. Prediger RD; Franco JL; Pandolfo P; Medeiros R; Duarte FS; Di Giunta G; Figueiredo CP; Farina M; Calixto JB; Takahashi RN; Dafre AL Behav Brain Res; 2007 Feb; 177(2):205-13. PubMed ID: 17194489 [TBL] [Abstract][Full Text] [Related]
6. Atorvastatin prevents hippocampal cell death due to quinolinic acid-induced seizures in mice by increasing Akt phosphorylation and glutamate uptake. Piermartiri TC; Vandresen-Filho S; de Araújo Herculano B; Martins WC; Dal'agnolo D; Stroeh E; Carqueja CL; Boeck CR; Tasca CI Neurotox Res; 2009 Aug; 16(2):106-15. PubMed ID: 19526287 [TBL] [Abstract][Full Text] [Related]
7. Silibinin prevents amyloid beta peptide-induced memory impairment and oxidative stress in mice. Lu P; Mamiya T; Lu LL; Mouri A; Zou L; Nagai T; Hiramatsu M; Ikejima T; Nabeshima T Br J Pharmacol; 2009 Aug; 157(7):1270-7. PubMed ID: 19552690 [TBL] [Abstract][Full Text] [Related]
8. Beta-amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex. Jhoo JH; Kim HC; Nabeshima T; Yamada K; Shin EJ; Jhoo WK; Kim W; Kang KS; Jo SA; Woo JI Behav Brain Res; 2004 Dec; 155(2):185-96. PubMed ID: 15364477 [TBL] [Abstract][Full Text] [Related]
9. Neuronal seipin knockout facilitates Aβ-induced neuroinflammation and neurotoxicity via reduction of PPARγ in hippocampus of mouse. Qian Y; Yin J; Hong J; Li G; Zhang B; Liu G; Wan Q; Chen L J Neuroinflammation; 2016 Jun; 13(1):145. PubMed ID: 27287266 [TBL] [Abstract][Full Text] [Related]
10. Protective effect of meloxicam-loaded nanocapsules against amyloid-β peptide-induced damage in mice. Ianiski FR; Alves CB; Souza AC; Pinton S; Roman SS; Rhoden CR; Alves MP; Luchese C Behav Brain Res; 2012 Apr; 230(1):100-7. PubMed ID: 22342489 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of cellular prion protein (PrP(C)) prevents cognitive dysfunction and apoptotic neuronal cell death induced by amyloid-β (Aβ₁₋₄₀) administration in mice. Rial D; Piermartiri TC; Duarte FS; Tasca CI; Walz R; Prediger RD Neuroscience; 2012 Jul; 215():79-89. PubMed ID: 22537845 [TBL] [Abstract][Full Text] [Related]
12. Atorvastatin prevents cell damage via modulation of oxidative stress, glutamate uptake and glutamine synthetase activity in hippocampal slices subjected to oxygen/glucose deprivation. Vandresen-Filho S; Martins WC; Bertoldo DB; Mancini G; Herculano BA; de Bem AF; Tasca CI Neurochem Int; 2013 Jun; 62(7):948-55. PubMed ID: 23500607 [TBL] [Abstract][Full Text] [Related]
13. The HMG-CoA reductase inhibitor, atorvastatin, attenuates the effects of acute administration of amyloid-beta1-42 in the rat hippocampus in vivo. Clarke RM; O'Connell F; Lyons A; Lynch MA Neuropharmacology; 2007 Jan; 52(1):136-45. PubMed ID: 16920163 [TBL] [Abstract][Full Text] [Related]
14. Atorvastatin Improves Mitochondrial Function and Prevents Oxidative Stress in Hippocampus Following Amyloid-β Mancini G; Martins WC; de Oliveira J; de Bem AF; Tasca CI Mol Neurobiol; 2020 Oct; 57(10):4187-4201. PubMed ID: 32683653 [TBL] [Abstract][Full Text] [Related]
15. Sigma-1 (σ₁) receptor deficiency reduces β-amyloid(25-35)-induced hippocampal neuronal cell death and cognitive deficits through suppressing phosphorylation of the NMDA receptor NR2B. Yin J; Sha S; Chen T; Wang C; Hong J; Jie P; Zhou R; Li L; Sokabe M; Chen L Neuropharmacology; 2015 Feb; 89():215-24. PubMed ID: 25286118 [TBL] [Abstract][Full Text] [Related]
16. Antiamnesic and neuroprotective effects of the aminotetrahydrofuran derivative ANAVEX1-41 against amyloid beta(25-35)-induced toxicity in mice. Villard V; Espallergues J; Keller E; Alkam T; Nitta A; Yamada K; Nabeshima T; Vamvakides A; Maurice T Neuropsychopharmacology; 2009 May; 34(6):1552-66. PubMed ID: 19052542 [TBL] [Abstract][Full Text] [Related]